Vertex Pharmaceuticals (VRTX) Gross Margin (QoQ) (2009 - 2026)

Vertex Pharmaceuticals (VRTX) Gross Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -152.00
Mar 31, 2026 146.00
Dec 31, 2025 -112.00
Sep 30, 2025 26.00
Jun 30, 2025 -64.00
Mar 31, 2025 144.00
Dec 31, 2024 -38.00
Sep 30, 2024 -11.00
Jun 30, 2024 -132.00
Mar 31, 2024 188.00
Dec 31, 2023 -178.00
Sep 30, 2023 -46.00
Jun 30, 2023 -114.00
Mar 31, 2023 106.00
Dec 31, 2022 9.00
Sep 30, 2022 -48.00
Jun 30, 2022 -20.00
Mar 31, 2022 22.00
Dec 31, 2021 -2.00
Sep 30, 2021 79.00